HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013
- PMID: 27386014
- PMCID: PMC4911421
- DOI: 10.2174/1874613601610010127
HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013
Abstract
Objectives: Assess outcomes along the care continuum for HIV-infected people who inject drugs (PWID), by type of facility and stage of infection at diagnosis.
Methods: Data reported by 28 jurisdictions to the National HIV Surveillance System by December 2014 were used to identify PWID aged ≥13 years, diagnosed with HIV infection before December 31, 2013. Analyses used the CDC definition of linkage to care (LTC), retention in care (RIC), and viral suppression (VS), and are stratified by age, sex, race/ethnicity, and type of facility and stage of HIV infection at diagnosis.
Results: Of 1,409 PWID diagnosed with HIV in 2013, 1,116 (79.2%) were LTC with the lowest percentages among males (78.4%); blacks (77.5%) ages 13-24 years (69.0%); those diagnosed in early stage infection (71.6%); and at screening, diagnostic, or referral agencies (60.0%). Of 80,958 PWID living with HIV in 2012, 40,234 (49.7%) were RIC and 34,665 (42.8%) achieved VS. The lowest percentages for RIC and VS were among males (47.1% and 41.3% respectively); those diagnosed with late stage disease (47.1% and 42.4%); and young people. Whites had the lowest RIC (47.0%) while blacks had the lowest VS (41.1%).
Conclusion: Enhanced LTC activities are needed for PWID diagnosed at screening, diagnostic or referral agencies versus those diagnosed at inpatient or outpatient settings, especially among young people and blacks diagnosed in early stage infection. Less than half of PWID are retained in care or reach viral suppression indicating the need for continued engagement and return to care activities over the long term.
Keywords: AIDS; Care continuum; Facility at diagnosis; HIV; Injection drug use; Stage of infection.
References
-
- Office of National AIDS Policy National HIV/AIDS Strategy for the United States. Available at: https://aids.gov/federal-resources/national-hiv-aids-strategy/nhas-updat... . 2015. [Published July 2015. Accessed August 27, 2015].
-
- U.S. Preventive Services Task Force. Screening for HIV: Final Recommendation Statement. AHRQ Publication No. 12-05173-EF-3. Available at: http://www.uspreventiveservicestaskforce.org/uspstf13/hiv/hivfinalrs.htm . 2014. [Accessed May 27].
-
- Lansky A., Finlayson T., Johnson C., Holtzman D., Wejnert C., Mitsch A., Gust D., Chen R., Mizuno Y., Crepaz N. Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One. 2014;9(5):e97596. doi: 10.1371/journal.pone.0097596. - DOI - PMC - PubMed
-
- Centers for Disease Control and Prevention Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 U.S. dependent areas-2013. HIV Surveillance Supplemental Report 20 (No. 2). Available at: http://www.cdc.gov/hiv/pdf/library/reports /surveillance/cdc-hiv-surveil... . 2015. [Accessed May 5, 2015].
LinkOut - more resources
Full Text Sources
Other Literature Sources